Ajanta Pharma Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-24🗂️ Report periods on file: 2023-24, 2022-23, 2021-04 to 2022-03, 2020-04 to 2021-03

In its 2023-24 reporting, Ajanta Pharma Limited disclosed greenhouse gas emissions of 46.4K tCO2e/year (Scope 1 & 2). By scope: Scope 1: 6.4K tCO2e/year; Scope 2: 40.0K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
46.4K tCO2e/year (Scope 1 & 2)
2023-24
⚡
Renewable Energy
30%+
of total energy
💧
Water Usage
411.0K m3/year
2023-24
♻️
Waste
2.5K tons/year
2023-24

📊 Emissions by Scope (2023-24)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).6.4K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.40.0K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023-2446.4K tCO2e/year (Scope 1 & 2)
2022-238.6K tCO2e/year (Scope 1 & 2)
2021-04 to 2022-0351.2K tCO2e/year

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Increase renewable energy to over 50% in the next two years.
  • Reduce water consumption by 10% by 2025.
  • Reduce waste per unit of production by 10% annually and 30% by 2030.
  • Reduce energy consumption by 10% by 2026 and 15% by 2028.
  • Reduce Scope 1 and Scope 2 emissions by 10% by 2026 and 30% by 2030.

📅 Medium-term

  • Achieve 100% renewable energy by 2032.

🔭 Long-term

  • Net zero emissions by 2050 (implied)

🌱 ESG Focus Areas

Clean & Green Energy UtilisationSustainabilityWater NeutralityEmployee Well-beingHuman RightsResponsible SourcingEthical Business ConductCommunity Welfare

⚠️ Challenges & Risks +

  • Volatility in API prices and international logistics costs.
  • Tepid growth in the African market due to distributor inventory rationalisation.
  • Uncertainty in the African Institutional business due to reliance on procurement agencies' funding.

📋 Report Information

Reporting Period: 2023-24
Frameworks: GRI, BRSR